Vivek Wadhwa

1 week ago | flipboard.com | Vivek Wadhwa

7 hours ago'Honoured To Meet Him': Donald Trump Credits Asim Munir For Ending India-Pakistan WarDonald Trump said he was "honoured" to host Pakistan Army Chief Asim Munir at the White House, thanking him for helping end the recent India-Pakistan …4 hours ago‘Complete breakdown during video call’: Bengaluru man hospitalised after CEO’s brutal outburstA Bengaluru startup employee experienced severe verbal harassment from the CEO, leading to a panic attack during a video call. A Bengaluru startup …

1 week ago | siliconeer.com | Vivek Wadhwa

President Trump’s sweeping cuts to research funding and restrictions on international students aren’t just trimming waste, they’re demolishing America’s innovation engine. With $2.7 billion in research frozen, universities like Harvard and MIT scrambling, and top global talent fleeing to competitors, these policies threaten the very foundation of U.S. scientific leadership.

2 weeks ago | indiacurrents.com | Vivek Wadhwa

Hyderabad-based Mapmygenome’s acquisition of Canada’s Microbiome Insights marks a critical moment in healthcare. It provides a platform to marry modern science with the wisdom and insight of Ayurveda. That, in turn, will allow India to lead a transformation in global healthcareLast week, Hyderabad-based Mapmygenome made headlines by acquiring Microbiome Insights, a Canadian company known for its cutting-edge work in microbiome research.

2 weeks ago | htsyndication.com | Vivek Wadhwa

India, June 11 -- The future of human reproduction and genetic design is accelerating faster than most people understand, driven not by national debates or international accords, but by software startups, biotech investors, and quiet breakthroughs in fertility clinics. Nucleus Genomics recently unveiled Nucleus Embryo, a genetic screening platform that allows prospective parents to assess up to 20 embryos for more than 900 conditions and traits.

2 weeks ago | hindustantimes.com | Vivek Wadhwa

The future of human reproduction and genetic design is accelerating faster than most people understand, driven not by national debates or international accords, but by software startups, biotech investors, and quiet breakthroughs in fertility clinics. Nucleus Genomics recently unveiled Nucleus Embryo, a genetic screening platform that allows prospective parents to assess up to 20 embryos for more than 900 conditions and traits.